Navigation Links
Study unveils SINE's potential of re-activating tumor fighting proteins within a cell
Date:11/15/2013

Arnhem, The Netherlands - New study suggests that selective blockade of CRM1-dependent nuclear export represents a completely novel, tumour metastasis-selective approach for the treatment of advanced metastatic prostate cancers.

According to the researchers, the human nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 (CRM1) is the sole exportin mediating transport of many multiple tumor suppressor proteins out of the nucleus. Their study aimed to verify the hypothesis that CRM1 inhibition could be beneficial for the treatment of prostate cancer metastases, which was achieved by testing the effects of the orally available, potent and selective, clinical stage SINE compound KPT 330.

"Although the class of compounds used in our studies SINEs or Selective Inhibitors of Nuclear Export have just recently entered early clinical testing, our results suggest that these agents could be active in patients with androgen-independent prostate cancer," commented study's lead author Dr. Claudio Festuccia, of the University of L'Aquila in Italy.

"Most of the current treatments for prostate cancer work by reducing the levels or blocking the receptors for a set of hormones called androgens. These SINE compounds act through an entirely new mechanism by re-activating a cells own tumor fighting proteins. These tumor fighting proteins, called tumor suppressor proteins, act as a guardian against the development of cancers by detecting damage to a cell's DNA and if DNA damage is found, activating the cell's own suicide program," he explained.

"Since all cancers have a great deal of DNA damage, re-activation of tumour suppressor proteins could cause the cancer to commit suicide. We observed just such an effect with these new SINE drug candidates."

According to the authors, the study also showed that these new SINE drug candidates prevented prostate cancer cells from causing damage to bones.

"The mechanisms of preventing the damage are now being worked out, but it appears that these new SINE drug candidates can suppress a type of bone cell called an osteoclast," said Festuccia.

Osteoclasts are activated by prostate cancer cells to destroy bone, and play an important role in prostate cancer-associated bone disease.


'/>"/>

Contact: Evgenia Starkova
e.starkova@uroweb.org
31-263-890-680
European Association of Urology
Source:Eurekalert

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study reveals how cancer drug causes diabetic-like state
3. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. No Added Cancer Risk From Hip Replacement Materials: Study
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Early Study Finds Some Promise for Lung Cancer Vaccine
9. Narcissists Often Ace Job Interviews, Study Finds
10. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
11. Soy may alleviate hot flashes in menopause, large-scale study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/24/2018)... ... ... Oak Street Health , a network of health centers providing a ... center to its Chicago operations. With the addition of Little Village, Oak Street Health ... providing care for adults on Medicare in areas where health care is needed most. ...
(Date:9/24/2018)... ... 2018 , ... A device that more than 80 percent ... for soldiers suffering from traumatic brain injuries (TBI) and infectious diseases, thanks to ... researchers are developing machine learning algorithms that will sort through a host of ...
(Date:9/22/2018)... (PRWEB) , ... September 21, 2018 , ... Liz Dudek, ... at the Sept. 25 Hillsborough County Chapter meeting of the Florida Assisted Living Association ... Brandon, Florida. , Dudek’s presentation will provide an overview of the success of ...
(Date:9/22/2018)... ... September 22, 2018 , ... Nonprofit and not-for-profit organizations ... different categories listed in section 501(c) of the Internal Revenue Code under which ... as a 501(c)(3)), private foundations, political organizations, and others such as chambers of ...
(Date:9/15/2018)... (PRWEB) , ... September 14, 2018 , ... ... includes, among other funding, full FY 2019 appropriations for Labor, Health and Human ... funding for the evidence-based Teen Pregnancy Prevention (TPP) Program, and $286.5 million for ...
Breaking Medicine News(10 mins):
(Date:9/12/2018)... ... September 13, 2018 , ... Donaldson Plastic Surgery has been included on ... Business First's Fast 50 list of central Ohio's fastest growing businesses. The plastic surgery ... of 81 percent. It is the only medical practice and plastic surgery office to ...
(Date:9/7/2018)... FOLSOM, Calif. (PRWEB) , ... September 06, 2018 , ... ... Best Overall Scientific Paper Award for his presentation of: IDEAL IMPLANT® - Seven-Year Clinical ... asked to present the paper again at the upcoming ASPS (American Society of Plastic ...
(Date:9/7/2018)... ... 07, 2018 , ... New York City is currently the epicenter of the ... of claiming the fourth and final jewel in the 2018 grand slam crown – ... Seldom, however, will the players’ footwork be highlighted. , “Today’s tennis isn’t that of ...
Breaking Medicine Technology: